Literature DB >> 34352262

Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review.

Trisha Kaundinya1, Uros Rakita2, Armaan Guraya3, Donna Maria Abboud4, Emily Croce5, Jacob P Thyssen6, Andrew Alexis7, Jonathan I Silverberg8.   

Abstract

The psychometric validity and reliability of widely used atopic dermatitis (AD) outcome measures across different races and ethnicities are unclear. We describe the rates of reporting race, ethnicity, and skin tone in studies testing the psychometric properties of AD outcome measures and compare the psychometric analyses across race, ethnicity, and skin tone. We systematically reviewed MEDLINE and EMBASE for studies reporting psychometric properties of clinician-reported or patient-reported outcome measures in AD (International Prospective Register of Systematic Reviews: CRD42021239614). Overall, 16,100 nonduplicate articles were screened; 165 met inclusion criteria. Race and/or ethnicity were reported in 55 (33.3%) studies; of those, race was assessed by self-report in 10 studies (6.1%) or was unspecified in 45 (27.3%). A total of 16 studies (9.7%) evaluated psychometric property differences by race, and only five (4.4%) of those did not recognize it as a limitation. Properties assessed across race, ethnicity, or skin tone were differential item functioning, convergent validity feasibility, inter-rater reliability, intrarater reliability, test‒retest reliability, and known-groups validity. Multiple instruments demonstrated performance differences across ethnoracial groups. This review highlights the paucity of race/ethnicity consideration for psychometric property testing in AD outcome measurement instruments. More AD outcomes instruments should be validated in diverse populations.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34352262      PMCID: PMC8792149          DOI: 10.1016/j.jid.2021.06.033

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  164 in total

1.  The impact of childhood atopic dermatitis on the patients' family.

Authors:  Hani A Al Shobaili
Journal:  Pediatr Dermatol       Date:  2010-11-16       Impact factor: 1.588

2.  Quantification of the extent and the severity of atopic dermatitis: the ADASI score.

Authors:  F A Bahmer; J Schäfer; H J Schubert
Journal:  Arch Dermatol       Date:  1991-08

3.  Severity scoring of atopic dermatitis: a comparison of three scoring systems.

Authors:  A B Sprikkelman; R A Tupker; H Burgerhof; J P Schouten; P L Brand; H S Heymans; W M van Aalderen
Journal:  Allergy       Date:  1997-09       Impact factor: 13.146

4.  Agreement between dermatologic and pediatric researchers in scoring of atopic dermatitis in children.

Authors:  Arturo Borzutzky; Rodrigo Hoyos-Bachiloglu; Cristián Navarrete-Dechent; Cristián Vera-Kellet; Sergio Silva-Valenzuela; Lorena Cifuentes; Carolina Iturriaga; Francisca Cristi
Journal:  Pediatr Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.588

5.  Assessing the Impact of Atopic Dermatitis on the Patients' Parents with the Visual Instrument 'Caregiver-PRISM'.

Authors:  Elena Marinello; Dennis Linder; Andrea Spoto; Katie Palmer; Peter Michael Rohrer; Stefan Büchi; Michael Trapp; Eva-Maria Trapp; Nina Hoerlesberger; Stefano Piaserico; Andrea Peserico; Michela Gatta; Anna Belloni Fortina
Journal:  Dermatology       Date:  2016-08-25       Impact factor: 5.366

6.  Validation of patient-reported global severity of atopic dermatitis in adults.

Authors:  P P Vakharia; R Chopra; R Sacotte; N Patel; S Immaneni; T White; R Kantor; D Y Hsu; J I Silverberg
Journal:  Allergy       Date:  2017-10-09       Impact factor: 13.146

7.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

8.  Does age or gender influence quality of life in children with atopic dermatitis?

Authors:  K L E Hon; T F Leung; K Y Wong; C M Chow; A Chuh; P C Ng
Journal:  Clin Exp Dermatol       Date:  2008-08-02       Impact factor: 3.470

9.  How should minimally important change scores for the Patient-Oriented Eczema Measure be interpreted? A validation using varied methods.

Authors:  L Howells; S Ratib; J R Chalmers; L Bradshaw; K S Thomas
Journal:  Br J Dermatol       Date:  2018-04-17       Impact factor: 9.302

10.  Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.

Authors:  Zehui He; Chuanjian Lu; Mary-Margaret Chren; Zhongzhao Zhang; Yan Li; Xiaojia Ni; Henry A Buchtel V; Paul F Ryan; Guo-Zheng Li
Journal:  Health Qual Life Outcomes       Date:  2014-12-24       Impact factor: 3.186

View more
  1 in total

1.  Validation of remote atopic dermatitis severity assessment with the Eczema Area and Severity Ondex in children using caregiver-provided photos and videos.

Authors:  Emily A Croce; Paul J Rathouz; Fabiana C P S Lopes; Maria Leszczynska; Lucia Z Diaz; Moise L Levy; Jennifer S Ruth; Pooja Varshney; Lynn Rew; Elizabeth C Matsui
Journal:  Pediatr Dermatol       Date:  2022-05-06       Impact factor: 1.997

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.